PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
Proteolysis Targeting Chimera (PROTACs) are a brand-new concept of therapeutics that use the ubiquitin-proteasome system for selective degradation of disease-related proteins. Like other therapeutics, PROTACs function by recruiting a protein target and a ubiquitin ligase that leads to the degradati...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
German Journal of Pharmaceuticals and Biomaterials
2025-01-01
|
| Series: | German Journal of Pharmaceuticals and Biomaterials |
| Subjects: | |
| Online Access: | https://www.gjpb.de/index.php/gjpb/article/view/154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|